Literature DB >> 29424450

Mayo CALR mutation type classification guide using alpha helix propensity.

Terra L Lasho1, Christy M Finke1, Alexander Tischer1, Animesh Pardanani1, Ayalew Tefferi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29424450     DOI： 10.1002/ajh.25065

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions.

Authors:  Hannah Goulart; John Mascarenhas; Douglas Tremblay
Journal:  Ann Hematol       Date:  2022-03-28       Impact factor: 3.673

2.  Mutations and thrombosis in essential thrombocythemia.

Authors:  Paola Guglielmelli; Naseema Gangat; Giacomo Coltro; Terra L Lasho; Giuseppe Gaetano Loscocco; Christy M Finke; Erika Morsia; Benedetta Sordi; Natasha Szuber; Curtis A Hanson; Animesh Pardanani; Alessandro M Vannucchi; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2021-04-27       Impact factor: 11.037

3.  CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms.

Authors:  Tanja Belcic Mikic; Tadej Pajic; Matjaz Sever
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

Review 4.  The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms.

Authors:  Tanja Belčič Mikič; Tadej Pajič; Samo Zver; Matjaž Sever
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.